The board (the "Board") of directors (the "Directors") of JW (Cayman) Therapeutics Co. Ltd. announces that, with effect from January 1, 2023, Mr. Chi Shing Li ("Mr. Li") has resigned as an independent non-executive Director and the chairman of the Remuneration Committee of the Board (the "Remuneration Committee") and Nomination Committee of the Board (the "Nomination Committee") due to personal reason.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 HKD | +0.55% | +4.57% | -19.03% |
Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
Mar. 20 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.03% | 93.83M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- 2126 Stock
- News JW (Cayman) Therapeutics Co. Ltd
- JW Therapeutics Co. Ltd Announces Resignation of Chi Shing Li as Independent Non-Executive Director and the Chairman of the Remuneration Committee of the Board and Nomination Committee of the Board, Effective January 1, 2023